Evidence map›Paper›PMID 30804709›Full record

ArticleCancer cell international2019

Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals.

Abdel-Moneim M Osman, Suad A Telity, Zoheir A Damanhouri, Sameer E Al-Harthy, Huda M Al-Kreathy, Wafaa S Ramadan, Mohamed F Elshal, Lateef M Khan, Fatemah Kamel

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer cell international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Abdel-Moneim M Osman1Pharmacology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, Saudi Arabia.
Suad A Telity1Pharmacology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, Saudi Arabia.
Zoheir A Damanhouri1Pharmacology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, Saudi Arabia.
Sameer E Al-Harthy1Pharmacology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, Saudi Arabia.
Huda M Al-Kreathy1Pharmacology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, Saudi Arabia.
Wafaa S Ramadan3Anatomy Department, Faculty of Medicine, King Abdul Aziz University, P.O. Box 80205, Jeddah, Saudi Arabia.
Mohamed F Elshal4Department of Biochemistry, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah, Saudi Arabia.
Lateef M Khan1Pharmacology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, Saudi Arabia.
Fatemah Kamel1Pharmacology Department, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, Saudi Arabia.
King Abdulaziz University · SAMenoufia University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1186/s12935-014-0152-2.].

Identifiers

PMID30804709
PMCPMC6371602
OpenAlexW2940225899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.